Wen-Hung Chen
Overview
Explore the profile of Wen-Hung Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Raymond K, Maher S, Saucier C, OConnor M, Yarlas A, Kosinski M, et al.
Rheumatol Ther
. 2022 Oct;
10(1):95-115.
PMID: 36227531
Introduction: The Profile of Fatigue and Discomfort-Sicca Symptoms Inventory-Short Form (PROFAD-SSI-SF) is a 19-item patient-reported outcome (PRO) measure to assess pain, fatigue, and dryness in patients with primary Sjögren's syndrome...
12.
Eremenco S, Chen W, Blum S, Bush E, Bushnell D, DeBusk K, et al.
Qual Life Res
. 2022 Jul;
31(12):3501-3512.
PMID: 35854060
Purpose: Score reproducibility is an important measurement property of fit-for-purpose patient-reported outcome (PRO) measures. It is commonly assessed via test-retest reliability, and best evaluated with a stable participant sample, which...
13.
Kharawala S, Kaur G, Shukla H, Scott D, Hawkins N, Chen W, et al.
Lupus
. 2022 May;
31(9):1029-1044.
PMID: 35607279
Background: Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease characterized by abnormal B-cell activation and the presence of autoantibodies, which can result in organ damage. Lupus nephritis (LN) is...
14.
Sullivan H, Chen W, Betts K
Commun Methods Meas
. 2021 Oct;
15(3).
PMID: 34616499
Researchers frequently measure recognition of information in health messages by presenting participants with statements that were or were not in a message and then asking them to identify which were...
15.
Huang N, Lien L, Chen W
Acta Neurol Taiwan
. 2021 May;
29(4):114-118.
PMID: 34018170
Objective: Macrophage activation syndrome (MAS) or reactive hemophagocytic lymphohistiocytosis (HLH) refers to a set of clinical symptoms caused by the excessive activation and proliferation of macrophages. It was linked with...
16.
Stover A, McLeod L, Langer M, Chen W, Reeve B
J Patient Rep Outcomes
. 2019 Jul;
3(1):50.
PMID: 31359210
Background: This paper is part of a series comparing different psychometric approaches to evaluate patient-reported outcome (PRO) measures using the same items and dataset. We provide an overview and example...
17.
Chen W, Yeh H, Tsao C, Lien L, Chiwaya A, Alizargar J, et al.
Dis Markers
. 2018 Jul;
2018:9831079.
PMID: 30034558
Translocator protein 18 kDa (TSPO) has been used as a biomarker of brain injury and inflammation in various neurological diseases. In this study, we measured the level of TSPO in...
18.
Chan F, Hsu C, Li T, Chen W, Tseng K, Chao P
J Nutr Biochem
. 2018 Jun;
58:150-157.
PMID: 29957359
The α-eleostearic acid (α-ESA) in bitter melon seed oil (BMSO) is efficiently converted by the body into rumenic acid. The objective of this study was to investigate effects of BMSO...
19.
Chen W, Chou F, Wang Y, Huang S, Cheng C, Wu T
Virol J
. 2017 Oct;
14(1):189.
PMID: 28969658
Background: Dengue virus (DV) infection causes a spectrum of clinical diseases ranging from dengue fever to a life-threatening dengue hemorrhagic fever. Four distinct serotypes (DV1-4), which have similar genome sequences...
20.
The anti-adiposity effect of bitter melon seed oil is solely attributed to its fatty acid components
Chen G, Chen W, Tseng K, Chao P
Lipids Health Dis
. 2017 Oct;
16(1):186.
PMID: 28962621
Background: Obesity is the leading chronic disease affecting people of all ages. The objective of this study was to optimize composition of a bitter melon seed oil (BMSO) product to...